Anat Cohen-Dayag
CIK: 0001907035
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CGEN
COMPUGEN LTD
Director
Discretionary Trading P&L
Holdings
About Cohen-Dayag Anat
Cohen-Dayag Anat (SEC CIK 0001907035) files insider reports with the SEC as Director of COMPUGEN LTD (CGEN).
Signal8 holds 2 ownership filings by Cohen-Dayag Anat (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Jul 30, 2026. Those filings report 1 transaction, the latest on Jul 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cohen-Dayag Anat's filings is in HOLON.
Recent filings by Cohen-Dayag Anat
- Jul 29, 2026: Grant or award of CGEN derivative securities (Form 4, code A).
Other insiders filing for COMPUGEN LTD (CGEN)
- Levine Zurit, SVP, Business Development
- Silberman David, Chief Financial Officer
- Ophir Eran, President and CEO
- Perry Eran, Director
- Ferre Pierre, Chief Operating Officer
- Kredo Russo Sharon, SVP, Research & Discovery